VMware (NYSE: VMW), DexCom (NASDAQ: DXCM), Synageva BioPharma (NASDAQ: GEVA), Microsoft (NASDAQ: MSFT), Insulet (NASDAQ: PODD), TripAdvisor (NASDAQ: TRIP) and VMware (NYSE: VMW) getting new coverage from analysts.
Brean Murray initiated coverage on DexCom (DXCM). They placed a “Buy” rating and a price target of $12.50 on the company.
Leerink Swann initiated coverage on Synageva BioPharma (GEVA). They placed a “Market Perform” rating on the company.
Raymond James (NYSE:RJF) initiated coverage on Microsoft (MSFT). They placed an “Outperform” rating and a price target of $34.00 on the company.
Brean Murray initiated coverage on Insulet (PODD). They placed a “Buy” rating and a price target of $24.00 on the company.
Goldman Sachs (NYSE:GS) initiated coverage on TripAdvisor (TRIP). They placed a “Neutral” rating on the company.
Evercore Partners initiated coverage on VMware (VMW). They placed an “Overweight” rating on the company.
Tuesday, January 17, 2012
VMware (VMW) (DXCM) (GEVA) (MSFT) (PODD) (TRIP) (VMW) Get New Coverage
Labels:
Goldman Sachs,
Microsoft
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment